DERMATOLOGY EDITION

Spesolimab, A Novel Interleukin-36 Inhibitor for Generalized Pustular Psoriasis Flares in Adult Patients

Explore the groundbreaking role of Spesolimab, a novel interleukin-36 inhibitor, in treating Generalized Pustular Psoriasis flares in adults. This article presents key findings from phase 1 and 2 clinical trials, emphasizing Spesolimab's effectiveness and safety.

FAMILY PRACTICE

Advertisement

STL - image

Newsletter & Free PDF with Latest Articles

From STL Archives:

Popular